meissa-vaccines

Meissa Vaccines Closes $3.4 Million Round to Advance RSV Vaccine to Clinic

Meissa Vaccines Closes $3.4 Million Round to Advance RSV Vaccine to Clinic

The Meissa team has developed a live attenuated vaccine with global utility.

JLABS resident Meissa Vaccines nabs new seed capital to advance RSV vaccine

JLABS resident Meissa Vaccines nabs new seed capital to advance RSV vaccine

Meissa was incorporated through QB3 Startup in a Box.